AR052155A1 - Compuestos organicos - Google Patents

Compuestos organicos

Info

Publication number
AR052155A1
AR052155A1 ARP050105195A ARP050105195A AR052155A1 AR 052155 A1 AR052155 A1 AR 052155A1 AR P050105195 A ARP050105195 A AR P050105195A AR P050105195 A ARP050105195 A AR P050105195A AR 052155 A1 AR052155 A1 AR 052155A1
Authority
AR
Argentina
Prior art keywords
pharmaceutically acceptable
water
insoluble
animal
human
Prior art date
Application number
ARP050105195A
Other languages
English (en)
Spanish (es)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR052155A1 publication Critical patent/AR052155A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ARP050105195A 2004-12-14 2005-12-12 Compuestos organicos AR052155A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04029498 2004-12-14

Publications (1)

Publication Number Publication Date
AR052155A1 true AR052155A1 (es) 2007-03-07

Family

ID=34927750

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105195A AR052155A1 (es) 2004-12-14 2005-12-12 Compuestos organicos

Country Status (16)

Country Link
JP (1) JP5372378B2 (de)
KR (1) KR101304160B1 (de)
CN (1) CN101056617B (de)
AR (1) AR052155A1 (de)
AT (1) ATE389386T1 (de)
AU (1) AU2005315823B2 (de)
BR (1) BRPI0519022A2 (de)
CA (1) CA2585779C (de)
DE (1) DE602005005522T2 (de)
ES (1) ES2301084T3 (de)
MX (1) MX2007007099A (de)
NZ (1) NZ554904A (de)
RU (1) RU2394558C2 (de)
TW (1) TWI369218B (de)
WO (1) WO2006063794A1 (de)
ZA (1) ZA200703506B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
BRPI0811319A2 (pt) 2007-05-25 2015-02-10 Tolmar Therapeutics Inc Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento
CN101159064B (zh) 2007-11-29 2010-09-01 腾讯科技（深圳）有限公司 画像生成系统以及按照图像生成画像的方法
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
JP6543431B2 (ja) * 2013-10-10 2019-07-10 ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 眼内薬物送達デバイスおよび付随する方法
EP3609470B1 (de) 2017-04-13 2023-11-22 Ceva Santé Animale Implantate zur behandlung von parasitenbefall
CN112336682B (zh) * 2020-09-28 2022-07-08 浙江大学 具有缓控释药物作用的可注射复合载体与组合物及制备方法
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
ES2158611T3 (es) * 1996-12-20 2001-09-01 Alza Corp Composicion en gel inyectable con efecto retard y procedimiento para la preparacion de dicha composicion.
ME00867B (me) * 1998-03-19 2008-08-07 Merck Sharp & Dohme Tečne polimerne smeše za kontrolisano oslobađanje bioaktivnih supstanci
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
JP4317606B2 (ja) * 1998-09-18 2009-08-19 サンスター株式会社 固体粒子形成用組成物
RU2355385C2 (ru) * 2002-11-06 2009-05-20 Алза Корпорейшн Композиции пролонгированного действия с контролируемым высвобождением
JP2007525429A (ja) * 2003-03-11 2007-09-06 キューエルティー ユーエスエー，インコーポレイテッド． 細胞スケジュール依存性抗癌剤のための処方

Also Published As

Publication number Publication date
ATE389386T1 (de) 2008-04-15
CA2585779C (en) 2014-01-28
ES2301084T3 (es) 2008-06-16
KR101304160B1 (ko) 2013-09-04
RU2007126759A (ru) 2009-01-27
CN101056617A (zh) 2007-10-17
MX2007007099A (es) 2007-06-22
AU2005315823A1 (en) 2006-06-22
RU2394558C2 (ru) 2010-07-20
JP2008523131A (ja) 2008-07-03
JP5372378B2 (ja) 2013-12-18
CN101056617B (zh) 2012-07-11
NZ554904A (en) 2009-11-27
DE602005005522T2 (de) 2009-04-16
WO2006063794A1 (en) 2006-06-22
DE602005005522D1 (de) 2008-04-30
BRPI0519022A2 (pt) 2008-12-23
CA2585779A1 (en) 2006-06-22
AU2005315823B2 (en) 2009-06-04
TW200635616A (en) 2006-10-16
KR20070092964A (ko) 2007-09-14
TWI369218B (en) 2012-08-01
ZA200703506B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
AR052155A1 (es) Compuestos organicos
Narayanaswamy et al. Hydrogels and their applications in targeted drug delivery
CA2273017C (fr) Dispositif d'administration locale de formulations solides ou semi-solides, formulations retard pour administration parenterale et procede de preparation
AR037462A1 (es) Composiciones polimericas de liberacion controlada de compuestos que promueven el crecimiento oseo, kit farmaceutico para su administracion y metodo para formar un implante in- situ
ES2116308T5 (es) Procedimiento para la produccion de un dispositivo implantable a base de un material polimero, que contiene principios activos farmaceuticos.
WO2006041942A3 (en) Ocular delivery of polymeric delivery formulations
NZ597621A (en) Sustained delivery formulations of risperidone compounds
PE20071139A1 (es) Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido
HRP20211853T1 (hr) Sastavi in situ injekcijskih biorazgradivih implantata
DE60209446D1 (de) Medizinische Implantatvorrichtung , Einführgerät und Implantierungsverfahren für ein Wirkstoff und Zellen enthaltendes Implantat
JP2017522365A (ja) 薬物送達システム及び関連する使用方法
ATE421316T1 (de) Herstellung von langzeit- arzneimittelabgabevorrichtungen mit polymeren auf polyurethanbasis
CA2623561A1 (en) Gelling hydrophobic injectable polymer compositions
RU2463079C2 (ru) Разделительные агенты для имплантируемого устройства и способы их применения
ATE332125T1 (de) Emulsionen für in-situ arzneistoffabgabesysteme
AR072668A1 (es) Encapsulacion de agentes biologicamente activos
RU2015109296A (ru) Системы доставки лекарственного средства и способы лечения рака мочевого пузыря, включающие применение оксалиплатина
HRP20221252T1 (hr) Sustavi isporuke lijeka i postupci za liječenje raka mokraćnog mjehura s gemcitabinom
AR118753A1 (es) Método de tratamiento de un niño con pubertad precoz central usando una composición de liberación prolongada
AR078165A1 (es) Adhesivo de hidrogel para protesis dentales, su preparacion
AR053799A1 (es) Composiciones que contienen policonasol y teaflavina y sus usos farmaceuticos
CN104208711A (zh) 壳聚糖半流体缓释凝胶及用途
DE102004031014A1 (de) Vorrichtung zur gezielten Freistzung von Stoffen in einem Hohlraum
Yadav et al. A Comprehensive Review on Gastro-retentive Drug Delivery System
JP2004534618A (ja) 再狭窄に対するビトロネクチン受容体アンタゴニストを有するステント

Legal Events

Date Code Title Description
FB Suspension of granting procedure